IL1B and Alzheimer disease: Studies report dynamic cytokine profiles along the DS‐AD spectrum, resembling an early and a late neuroinflammatory period, with early peaks of upregulated pro‐inflammatory markers like interleukin (IL)‐6, IL‐1β, IL‐15, and macrophage‐derived chemokine (MDC) around age 20.26